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Risk assessment models for potential use in
the emergency department have lower
predictive ability in older patients
compared to the middle-aged for
short-term mortality – a retrospective
cohort study
Martin Schultz1,2* , Line Jee Hartmann Rasmussen3, Nicolas Carlson4, Rasmus Bo Hasselbalch1,
Birgitte Nybo Jensen5, Lotte Usinger2, Jesper Eugen-Olsen3, Christian Torp-Pedersen6,7,
Lars Simon Rasmussen8 and Kasper Karmark Iversen1
Abstract
Background: Older patients is a complex group at increased risk of adverse outcomes compared to younger
patients, which should be considered in the risk assessment performed in emergency departments. We evaluated
whether the predictive ability of different risk assessment models for acutely admitted patients is affected by age.
Methods: Cohort study of middle-aged and older patients. We investigated the accuracy in discriminating between
survivors and non-survivors within 7 days of different risk assessment models; a traditional triage algorithm, a triage
algorithm with clinical assessment, vital signs, routine biomarkers, and the prognostic biomarker soluble urokinase
plasminogen activator receptor (suPAR).
Results: The cohort included 22,653 (53.2%) middle-aged patients (age 40–69 years), and 19,889 (46.8%) older
patients (aged 70+ years). Death within 7 days occurred in 139 patients (0.6%) in middle-aged patients and 596 (3.0%)
of the older patients. The models based on vital signs and routine biomarkers had the highest area under the curve
(AUC), and both were significantly better at discriminating 7-day mortality in middle-aged patients compared to older
patients; AUC (95% CI): 0.88 (0.84–0.91), 0.75 (0.72–0.78), P < 0.01, and 0.86 (0.82–0.90), 0.76 (0.73–0.78), P < 0.001. In a
subgroup of the total cohort (6.400 patients, 15.0%), the suPAR level was available. suPAR had the highest AUC of all
individual predictors with no significant difference between the age groups, but further research in this biomarker is
required before it can be used.
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Conclusion: The predictive value was lower in older patients compared to middle-aged patients for all investigated
models. Vital signs or routine biomarkers constituted the best models for predicting 7-day mortality and were better
than the traditional triage model. Hence, the current risk assessment for short-term mortality can be strengthened, but
modifications for age should be considered when constructing new risk assessment models in the emergency
department.
Keywords: Emergency department, Older patients, Risk assessment, Triage
Background
Emergency departments (EDs) must prioritise treatment
of patients of all ages and health status according to ur-
gency while counterbalancing the negative effects of ED
crowding on patient safety [1, 2]. EDs commonly employ
triage algorithms to assess risk and prioritise according
to the perceived urgency of patients’ conditions. These
algorithms typically consist of a combination of vital
signs and primary complaints for risk assessment [3].
Older patients aged 65 years and older account for 12–
24% of all ED visits; additionally, both the number of visits
and the utilisation of resources in the ED are increasing
[4, 5]. Compared to younger patients, the older often have
a greater burden of comorbidities, more severe illnesses
[4, 6, 7], and often present with atypical symptoms and
nonspecific complaints [4, 8, 9]. Therefore, older patients
constitute a complex group at high risk; within 3 months
following an ED visit 20% of older patients had been hos-
pitalised, 20% revisited the ED, and approximately 5%
were dead [5]. Additionally, age-related changes in physi-
ology may result in reduced variability and decreased re-
sponse to stress [10], rendering vital signs less useful for
assessment of urgency and severity of acute illness in the
older [10, 11]. However, none of the currently used triage
algorithms stratifies patients according to age [12].
Risk assessment in the ED can be done using one of the
traditional triage algorithms [12], but recent studies have
attempted to improve risk assessment using different ap-
proaches or adding new elements. Incorporation clinical
assessment is one possibility as physicians first clinical im-
pression is associated with morbidity and mortality, and
because ED staff using only clinical intuition can identify
patients at risk of death [13, 14]. Different vital signs are
associated with adverse outcome and using these in risk
scores or simply the number of abnormal vital signs can
identify patients at risk, providing a second approach for a
better risk assessment [15, 16]. A third possibility, is risk
assessment using the routine biomarkers analysed from
blood samples during acute admission. Many of these bio-
markers have value in risk stratification, in addition to
their diagnostic value. For instance C-reactive protein
(CRP) and albumin are associated with mortality, [17, 18]
and a statistical model containing eight routine bio-
markers has been shown to be significantly better in
predicting mortality compared to traditional triage [19].
Finally, newly discovered experimental biomarkers have
been found to carry prognostic information that allows for
an accurate risk discrimination [20–22]. One of these
prognostic biomarkers is soluble urokinase plasminogen
activator receptor (suPAR), which is associated with dis-
ease severity of several acute and chronic conditions, and
with length of stay, readmissions and mortality in ED pa-
tients [23–25].
The optimal and best approach, however, remains un-
determined. The aim of this study was to evaluate the
predictive ability of different models for risk assessment
regarding short-term mortality in ED patients and to
compare the accuracy of the models in middle-aged and
older patients.
Methods
Study design
For this study of middle-aged and older patients present-
ing at an ED, we used data from the TRIAGE II and TRI-
AGE III studies [26, 27]. In brief, the TRIAGE II study
was a prospective, interventional cluster-randomised trial
comparing a newly developed triage algorithm, which
adds a clinical assessment to a traditional triage algorithm
[27]. The TRIAGE III study was a cluster-randomised
interventional trial investigating the effect of introducing
the nonspecific prognostic biomarker soluble urokinase
plasminogen activator receptor (suPAR) as a routine blood
test in the ED [26, 28].
Setting
TRIAGE II and TRIAGE III included ED patients at Bis-
pebjerg Hospital and Herlev Hospital, Denmark; both are
University hospitals with 24-h acute care of patients, offer-
ing all internal medicine specialities, general and ortho-
paedic surgery, intensive care, and level-2 trauma care.
Patients
Patients’ first ED visit from the TRIAGE studies was in-
cluded, subsequent readmissions were excluded. Scientific
research use different age cut-offs to define older patients
ranging from 60 to 75 years [4], in the present study we
classified patients aged 40 to 69 years as middle-aged, and
patients aged 70+ years as older, in accordance with
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previous research from emergency departments [29–31].
Patients younger than 40 years were excluded. The TRI-
AGE studies included ED patients from the same loca-
tions in a continuous time period making the study
populations similar. To assess the different risk assess-
ment models, we combined the two study populations
into one large cohort for this study.
Data collection
Vital signs, triage categories, and results of blood tests
were recorded at the ED visit. Vital signs, blood tests
and triage categories were retrieved from local hospital
databases. Follow-up data on hospital admissions, dis-
charges, and diagnoses were obtained from the Danish
National Patient Registry, [32, 33] and vital status at the
end of each TRIAGE study was obtained from the Da-
nish Civil Registration System, using patients’ unique
Danish civil registration number.
Outcome measures
Outcomes were all-cause mortality within two and 7 days.
Risk assessment models
We assessed five different types of risk assessment
models in the ED; I) a traditional triage algorithm, II) a
triage algorithm with clinical assessment, III) vital signs,
IV) routine biomarkers, and finally, V) the experimental
biomarker suPAR, and compared the predictive abilities
of middle-aged patients to older patients.
Traditional triage algorithm
The commonly used triage algorithm in Denmark is a
local adaptation of “Adaptive Process Triage” (ADAPT),
[34] which is based on vital signs and the presenting
complaint [35, 36]. Patients are divided into five categor-
ies: Red (most urgent), Orange, Yellow, Green (least ur-
gent), and Blue (minor injuries). In this analysis, patients
triaged “Green” and “Blue” were combined. ADAPT is
similar to other traditional 5-level triage algorithms [12].
Triage with clinical assessment
“The Copenhagen Triage algorithm” (CTA) is a newly
developed triage algorithm with five categories (similar
to ADAPT) based on measurement of vital signs and
supplemental of oxygen, followed by a systematic clinical
assessment by the ED staff, permitting modification of
the final triage category [27].
Vital signs
The vital signs; heart rate, respiratory rate, arterial oxy-
gen saturation, systolic blood pressure, and temperature
were measured at arrival to the ED.
Routine biomarkers
In the present study, we included levels of albumin, CRP,
creatinine, haemoglobin, leukocyte count, sodium, po-
tassium, and platelets, as they are routinely measured
during acute admissions and were available.
Experimental biomarker
In recent years, several new biomarkers with prognostic
information have been discovered as promising risk as-
sessment tools for use in the ED [37]. suPAR is a non-
specific biomarker of inflammation associated with
mortality [21, 24].
Statistics
Continuous variables are presented with median and
interquartile range (IQR) or mean (standard deviation),
and categorical variables as number (n) and percentages
(%). Baseline characteristics were compared using the
chi-square test, Student’s two-sample t-test, and Wilcoxon
rank-sum test. The ability of triage, vital signs, and bio-
markers to discriminate on mortality was assessed using
the area under the curve (AUC) for receiver operating
characteristics curves. AUCs were compared using the
DeLong’s method [38]. Triage categories, vital signs, and
biomarkers were used as continuous variables in logistic
regression to calculate AUCs. Combined models were cre-
ated using multiple logistic regression. Patients with miss-
ing predictors were not included in the respective
analyses. A P-value below 0.05 was considered statistically
significant. Statistical analyses were performed in R ver-
sion 3.3.3 [39] using the pROC package [40].
Results
Study population
The TRIAGE II study included ED visits of 39,883 pa-
tients from March 1, 2015, to January 31, 2016, and the
TRIAGE III study included ED visits of 16,801 patients
from January 11, 2016, to June 6, 2016. After exclusion
of patients younger than 40 years, the combined cohort
consisted of 42,542 patients (75.1%). The mean (SD) age
was 67.2 (14.9) years, and 21,880 (51.4%) were women.
At inclusion, 22,653 (53.2%) were age 40–69 years (mid-
dle-aged), and 19,889 (46.8%) were aged 70+ years
(older). Death from all causes within 7 days occurred in
139 patients (0.6%) in the group of middle-aged patients
and in 596 (3.0%) in the group of older patients. All
baseline characteristics were significantly different when
comparing the two age-groups, except for temperature,
Table 1. The two TRIAGE populations were comparable
regarding age, sex, and outcomes, but minor, but statisti-
cally significant, differences in the levels of the bio-
markers were observed (Additional file 1: Table S1).
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Predictive ability of different risk assessment models
AUCs for 2-day and 7-day mortality for all five risk as-
sessment models stratified in age-groups are presented
in Table 2, individual vital signs and biomarkers in Add-
itional file 1: Table S2 and the AUCs regarding 7-day
mortality is presented in Additional file 1: Figure S1.
Traditional triage algorithm
ADAPT triage categories were recorded for 11,389
(50.3%) of middle-aged patients and 9746 (49.0%) of
older patients. Significantly fewer middle-aged patients
were triaged “Red” compared to the older, while more
were triaged “Green” (Table 1). No difference in the pre-
dictive ability of short-term, all-cause mortality was ob-
served between the two groups (Table 2):
Triage with clinical assessment
CTA triage categories were recorded for 7983 (35.2%) of
middle-aged patients and 6655 (33.5%) of older patients.
Comparison of the distribution in triage categories
showed significantly more middle-aged patients in the
“Yellow” category and less in the “Red” (Table 1). AUC
analyses showed better prognostic ability compared to
Table 1 Baseline characteristics at first visit at the emergency department. Patients are grouped according to their age; 40–69 years
(middle-aged) and 70+ years (older)
Middle-aged
N = 22,653
Older
N = 19,889
P
Female sex, n (%) 10,687 (47.2) 11,193 (56.3) < 0.001
Age (years), mean (SD) 55.5 (8.6) 80.7 (7.4)
Triage: ADAPT 11,389 (50.3) 9746 (49.0)
Triage category: Red, n (%) 418 (3.1) 482 (4.9) < 0.001
Triage category: Orange, n (%) 3376 (24.0) 3038 (31.2) 0.02
Triage category: Yellow, n (%) 3953 (36.3) 3428 (35.1) 0.49
Triage category: Green, n (%) 3642 (36.5) 2798 (28.7) < 0.001
Triage: CTA 7983 (35.2) 6655 (33.5)
Triage category: Red, n (%) 189 (2.4) 225 (3.4) < 0.001
Triage category: Orange, n (%) 1276 (16.0) 1143 (17.2) 0.05
Triage category: Yellow, n (%) 3092 (38.7) 2409 (36.2) 0.01
Triage category: Green, n (%) 3426 (42.9) 2878 (43.2) 0.70
Vital signs 13,200 (58.3) 10,992 (55.3)
Heart rate (beats/min), mean (SD), 86 (20) 85 (20) < 0.001
Arterial oxygen saturation (%), median (IQR) 97 (96–99) 96 (95–98) < 0.001
Respiratory rate (breaths/min), mean (SD) 17 (3) 18 (4) < 0.001
Systolic blood pressure (mmHg), mean (SD) 140 (25) 146 (29) < 0.001
Temperature (°C), mean (SD) 36.8 (0.8) 36.8 (0.8) 0.07
Biomarkers levels, n (%) 13,032 (57.5) 13,039 (65.6)
Albumin (g/L), median (IQR) 41 (37–47) 38 (34–41) < 0.001
Creatinine (μmol/L), median (IQR) 72 (60–87) 83 (66–111) < 0.001
CRP (mg/L), median (IQR) 4 (3–33) 11 (3–61) < 0.001
Haemoglobin (mmol/L), median (IQR) 8.6 (7.8–9.2) 7.9 (7.0–8.6) < 0.001
Leucocytes (× 109/L), median (IQR) 8.6 (6.6–11.3) 8.9 (6.8–11.8) < 0.001
Potassium (mmol/L), median (IQR), 3.9 (3.7–4.2) 4.0 (3.7–4.3) < 0.001
Sodium (mmol/L), median (IQR) 139 (136–141) 138 (135–141) < 0.001
Platelets (× 109/L), median (IQR) 245 (200–300) 242 (195–309) < 0.001
suPAR (ng/mL), median (IQR) 3.7 (2.8–5.2) 5.4 (4.0–7.5) < 0.001
Mortality
Mortality within 2-days, n (%) 73 (0.3) 263 (1.3) < 0.001
Mortality within 7-days, n (%) 139 (0.6) 596 (3.0) < 0.001
CRP C-reactive protein, IQR Interquartile range, SD Standard deviation, suPAR Soluble urokinase plasminogen activator receptor
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ADAPT, and no difference in the prognostic ability be-
tween age groups (Table 2).
Vital signs
A complete set of the five included vital signs was re-
corded in 13,200 (58.3%) of middle-aged- and 10,992
(55.3%) of older patients. Of five available vital signs,
four had a predictive value of 2-day and 7-day mortality
(not temperature). Of the remaining vital signs, the re-
spiratory rate had the highest AUC and was significantly
better at predicting short-term mortality among the
middle-aged than among the older (Additional file 1:
Table S2). Combining the vital signs (heart rate, arterial
oxygen saturation, systolic blood pressure, and respira-
tory rate) in a prediction model showed significantly bet-
ter predictive ability for short-term mortality among the
middle-aged compared to the older (Table 2).
Routine biomarkers
Included routine biomarkers measured at ED visit were
available in 13,032 (57.5%) of the middle-aged and
13,039 (65.6%) of the older. All routine biomarkers, ex-
cept for platelets, had an individual predictive value of
2-day and 7-day mortality in both groups. Levels of albu-
min, CRP, haemoglobin, and sodium were significantly
better at predicting short-term mortality in the
middle-aged patients (Additional file 1: Table S2). A
combined model consisting of seven biomarkers (plate-
lets not included) had significantly higher AUC in
predicting short-term mortality in the group of
middle-aged patients compared to the older (Table 2).
Experimental biomarker
suPAR was available in 3227 (14.2%) middle-aged- and
3173 (16.0%) of the older patients. Its predictive ability
was higher than individual vital signs or routine
biomarkers and comparable to the triage algorithm
(Additional file 1: Table S2). There was no difference ob-
served among age-groups (Table 2).
Overall predictive ability across age deciles
All-cause mortality within 7 days was increasing with in-
creasing age. Stratifying the study population according
to age deciles decreased the accuracy in all five risk as-
sessment models, Fig. 1. In the two triage algorithms,
this was not significant. The AUCs were significantly
lower in the models consisting of vital signs, biomarkers,
and suPAR when comparing age 50 and age 80 years,
p < 0.001.
Discussion
In this study of 42,452 acutely presenting patients, we
found that risk assessment models based on vital signs
and routine biomarkers, had the best predictive abilities
compared to the other risk assessment models tested;
both models were significantly better at discriminating
on short-term mortality in middle-aged patients com-
pared to older patients. Furthermore, all five risk assess-
ment models included in this study showed fair to good
abilities in discriminating between survivors and
non-survivors at 7 days, but lower AUCs for the older.
The traditional triage algorithm (ADAPT), which is
commonly used, was less accurate than the other models
but did not differ significantly between age groups. Most
of the included vital signs and biomarkers had individual
predictive value but combining them in models yielded
the highest accuracy. Among the individual routine bio-
markers, albumin and CRP had the highest AUCs and
performed significantly better in the middle-aged pa-
tients than in older patients. The experimental bio-
marker, suPAR, had the highest AUC of all investigated
individual predictors, and there was no significant differ-
ence in the predictive value between the age groups.
However, suPAR was only available in 14.2% of the
middle-aged patient and in 16.0% of the older patients
and only in patients from the TRIAGE III study, repre-
senting a small subgroup of the total cohort, which war-
rants further internal and external validation of the
predictive ability before it can be considered for use in
the ED. Importantly, our results demonstrate the instru-
mental value of employing vital signs as part of risk as-
sessment at triage, which previously have been
demonstrated to predict mortality, [15, 41] but the
Table 2 Comparison of AUCs in predicting short-term mortality
of patients acutely presenting at the emergency department,
grouped according to age: 40–69 years (middle-aged), and 70+
years (older)
AUC, 95% CI Middle-aged
N = 22,653
Older
N = 19,889
P
ADAPT, 2-day mortality 0.80 (0.73–0.87) 0.76 (0.72–0.81) 0.40
ADAPT, 7-day mortality 0.72 (0.66–0.78) 0.71 (0.67–0.74) 0.69
CTA, 2-day mortality 0.83 (0.77–0.89) 0.78 (0.73–0.84) 0.22
CTA, 7-day mortality 0.79 (0.73–0.85) 0.73 (0.69–0.76) 0.09
Vital signs, 2-day mortality 0.89 (0.84–0.94) 0.81 (0.77–0.86) 0.02
Vital signs, 7-day mortality 0.88 (0.84–0.91) 0.75 (0.72–0.78) < 0.001
Biomarkers, 2-day mortality 0.84 (0.78–0.90) 0.75 (0.71–0.79) 0.02
Biomarkers, 7-day mortality 0.86 (0.82–0.89) 0.76 (0.73–0.78) < 0.001
suPAR, 2-day mortality 0.82 (0.66–0.97) 0.73 (0.64–0.81) 0.32
suPAR, 7-day mortality 0.82 (0.73–0.91) 0.77 (0.72–0.82) 0.32
ADAPT Adaptive process triage, AUC Area under the curve, CI Confidence
interval, CRP C-reactive protein, CTA Copenhagen triage algorithm, suPAR
Soluble urokinase plasminogen activator receptor, Vitals: Prediction model
using four vital signs (hear rate, oxygen saturation, respiratory rate, systolic
blood pressure), Biomarker: Predictive model using levels of seven routine
biomarkers (albumin, creatinine, c-reactive protein, haemoglobin, leucocytes,
potassium, sodium)
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predictive value is not equal across age groups. Vital
signs have previously shown to be less predictive in the
older prior to cardiac arrest and at triage [11, 42]. Add-
itionally, vital signs have increased sensitivity when ob-
served as serial measurements and might provide the
best information with an individualised reference range,
[10] however, this is not viable in the ED. Constructing
age-dependent reference ranges or cut-offs for use in tri-
age would be an alternative solution. We also demon-
strate that use of routine biomarkers in risk assessment
models could improve discriminative ability, but trans-
ference of these models directly into clinical use remains
complicated. The performance of the investigated
models in this study is comparable to other risk assess-
ment tools of mortality assessed in a systematic review
of scores based on different composition of vital signs
and biomarkers [43]. In the cohort of middle-aged pa-
tients, our models of vital signs and biomarkers were
comparable to the best performing tools in the review,
which both used age and incorporated either vital signs
or biomarkers.
Current triage algorithms have been validated to a limited
extent in older patients, [3] and there is little or no evidence
regarding performance in older patients or using
age-adjustment among the most commonly used triage al-
gorithms [12]. Only the Emergency Severity Index (ESI) al-
gorithm has been investigated with regard to older patients,
results were however conflicting [44–46]. Interestingly, the
inclusion of age has been proposed in different track-
and-trigger systems and predictions models, based on a
perceived augmentation of predictive accuracy [47–51].
Furthermore, the physiological scoring systems, Simplified
Acute Physiology Score (SAPS II) [52] and Acute Physi-
ology And Chronic Health Evaluation (APACHE) [51],
which are used for risk stratification of severity and risk of
mortality in intensive care, include age. Finally, important
Fig. 1 Area under the Curve for Receiver operating characteristics for all-cause mortality within 7 days for acutely admitted patients. The graph
presents five different approaches to risk assess patients acutely presenting at the emergency department. Patients are stratified in age deciles
according to their age at the first visit. The five approaches include; Two different triage algorithms; Adaptive Process Triage (ADAPT) and
Copenhagen Triage Algorithm (CTA), a predictive model using four vital signs (heart rate, arterial oxygen saturation, respiratory rate and systolic
blood pressure), a predictive model using levels of seven routine biomarkers (albumin, creatinine, c-reactive protein, haemoglobin, leucocytes,
potassium, sodium), and the experimental biomarker soluble urokinase plasminogen activator receptor (suPAR). Mortality in age deciles; 40: 0.2%,
50: 0.4%, 60: 1.0%, 70: 1.9%, 80: 3.6%, 90: 5.2%
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factors affecting outcome for older patients are functional
and cognitive status and comorbidity [53]. Incorporating
these factors may increase the accuracy of the triage algo-
rithm and lead to better management and treatment of
older patients.
In summary, risk assessment can be strengthened using
one of the described models, however, modifications for
patients over 70 years of age should be considered. Our
results indicate that incorporating age may improve the
accuracy of risk assessment in older patients in future tri-
age, but factors like functional and cognitive status should
also be considered. Furthermore, new models should be
validated in external cohorts before implementation. The
experimental biomarker suPAR shows promise in the
current study, but the results can only be considered as
hypothesis-generation. Further research in this biomarker,
the potential use, and possible interventions to elevated
levels is warranted. Whether a new or redesigned triage al-
gorithm will lead to better management and prognosis of
older patients will require further prospective interven-
tional studies.
Strengths and limitations
This retrospective study combined two large prospectively
collected cohorts from interventional trials conducted at
two hospitals with inclusion of a representative and unse-
lected cohort presenting around the clock, all days of the
week, which is a major strength of the study. This study
has several limitations. Patients with missing data were not
included in the analyses, potentially causing a selection bias
within the different risk assessment models investigated (i.e.
patients with missing biomarkers (no blood analysis done)
might be healthier than patients who had blood tests). Fur-
thermore, although the missing data might not affect the
comparison between age groups, the large difference in
missing data (ADAPT missing in 50.3%, CTA: 65.9%, vital
signs; 43.1%, biomarkers: 38.7%, and suPAR is missing in
85.0% of the total cohort) in the investigated models makes
comparison of the risk assessment models difficult and
should be interpreted with caution. Therefore, these results
are only suitable for hypothesis generation. Measurement
of vital signs are associated with some uncertainty, the
temperature was measured using an ear thermometer,
which might lead to underestimation of the actual
temperature. All vital signs were recorded by hand and later
entered manually in the database, which increases the risk
of errors. The biomarker-based model in our study is based
on the actual measurement value of the individual bio-
markers, and this is not easy to implement in the clinical
setting. Additionally, it is currently unknown whether they
will have an impact when used as prognostic tools. This is
also the case, regarding the experimental biomarker suPAR.
This nonspecific marker of immune activation have previ-
ously demonstrated strong prognostic abilities, but only
one trial has prospectively studied suPAR as a risk stratifi-
cation tool and found no effect on mortality [26]. The
suPAR level was only available in a small proportion of the
total cohort and analysis of suPAR is not routinely per-
formed in the ED, making it unavailable in most places or
associated with increased costs. The investigated patients
represent a subgroup of ED patients and the results might
not be transferrable to different settings or in patients with-
out need for blood sampling. Further research in the use
this biomarker is required, before it can be considered for
routine clinical use. The accuracy of the investigated triage
algorithms might be artificially lower in the analyses, as a
well-performing triage possibly translates to faster treat-
ment of risk patients, hence lowering the risk of mortality.
Furthermore, when the triage categories are used in the lo-
gistic models with only four levels, there is a limitation on
the calculated AUC. Finally, we have not included comor-
bidity or diagnoses in our analyses, which would allow fur-
ther stratification and precision in the models.
Conclusion
The predictive ability of mortality in acutely admitted pa-
tients was lower in older patients compared to middle-aged
patients in all investigated models, therefore modifications
for age should be considered when constructing risk assess-
ment model for use in the emergency department. Models
based on vital signs or routine biomarkers provided the best
models for prediction of 7-day mortality.
Additional file
Additional file 1: Table S1. Comparison of Baseline characteristics of
the TRIAGE II study and TRIAGE III study. Patients above 40 years were
included in the current study Table S2. Comparison of AUCs of
individual predictors in discriminating short-term mortality of ED patients,
grouped according to age: 40–69 years (middle-aged), and 70+ years
(older). Figure S1. Area under the Curve (AUC) for Receiver operating
characteristics for all-cause mortality within 7 days for acutely admitted
patients. Comparison of patients aged 40-69 (Middle-aged, blue colour),
and patients aged 70+ (Older, red colour). The graph presents four differ-
ent approaches of risk assessment of patients acutely presenting at the
emergency department. Two different triage algorithms; Adaptive Process
Triage (ADAPT) and Copenhagen Triage Algorithm (CTA), a predictive
model using four vital signs (heart rate, arterial oxygen saturation, respira-
tory rate and systolic blood pressure), and a predictive model using levels
of seven routine biomarkers (albumin, creatinine, c-reactive protein,
haemoglobin, leucocytes, potassium, sodium). (DOCX 241 kb)
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